Número total de visitas
Visualizaciones | |
---|---|
CEMCAT ... | 254 |
Visitas al mes
octubre 2023 | noviembre 2023 | diciembre 2023 | enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | |
---|---|---|---|---|---|---|---|
CEMCAT ... | 4 | 6 | 4 | 9 | 8 | 5 | 14 |
Países con más visualizaciones
Visualizaciones | |
---|---|
España | 121 |
Estados Unidos | 43 |
Irlanda | 11 |
China | 10 |
Suecia | 10 |
Costa de Marfil | 5 |
Francia | 4 |
Corea del Sur | 4 |
Reino Unido | 3 |
Japón | 3 |
Ciudades con más visualizaciones
Visualizaciones | |
---|---|
Barcelona | 65 |
Chandler | 12 |
Dublin | 11 |
Capellades | 10 |
Sant Feliu de Llobregat | 5 |
Ashburn | 4 |
Busan | 4 |
Daloa | 4 |
Shanghai | 4 |
Badalona | 3 |
Documentos más visitados
Visualizaciones | |
---|---|
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results | 491 |
Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care | 295 |
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome | 286 |
Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study | 243 |
Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study | 225 |
Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions | 108 |
The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction | 100 |
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure | 99 |
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets | 95 |
Cognitive assessment in patients with multiple sclerosis: A Spanish consensus | 89 |